Nueva York (CNN Business) . Las Malas Noticias siguen llegando para Johnson & Johnson . La Compañía Anunció el Viernes un Retiro Voluntario de su popular Talco para Bebés después de que se Descubriera que algunas Botellas contenían Pequeñas Cantidades de Asbesto.

Mientras tanto para PharmaMar lo que llegan continuamente ... Son Buenas Noticias :

El Asbesto provoca Mesothelioma . Un tipo de Cáncer para el que hay poquísimas armas ...  y si nos referimos a los Tratamientos de Segunda Línea nada hay .

Resulta curioso que durante la celebración en Barcelona del Congreso ESMO hace unos días se presentarán Resultados de Fase II Prometedores precisamente contra el Mesothelioma en Segunda Línea y que el Fármaco que ha conseguido incluso una Curación Total en un Paciente sea ... ZEPSYRE DE PHARMAMAR .

PharmaMar . Read This Before Selling Pharma Mar, S.A. (BME:PHM) Shares .

 Simply Wall St

15 mins ago

We’ve lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. On the other hand, we’d be remiss not to mention that insider sales have been known to precede tough periods for a business. So we’ll take a look at whether insiders have been buying or selling shares in Pharma Mar, S.A. (BME:PHM).

What Is Insider Buying?

It’s quite normal to see company insiders, such as board members, trading in company stock, from time to time. However, rules govern insider transactions, and certain disclosures are required.

Insider transactions are not the most important thing when it comes to long-term investing. But it is perfectly logical to keep tabs on what insiders are doing. As Peter Lynch said, ‘insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

View our latest analysis for Pharma Mar

The Last 12 Months Of Insider Transactions At Pharma Mar

Over the last year, we can see that the biggest insider purchase was by insider María Blanca Hernández Rodríguez for €58k worth of shares, at about €1.80 per share. So it’s clear an insider wanted to buy, at around the current price, which is €2.06. Of course they may have changed their mind. But this suggests they are optimistic. If someone buys shares at well below current prices, it’s a good sign on balance, but keep in mind they may no longer see value. Happily, the Pharma Mar insider decided to buy shares at close to current prices. María Blanca Hernández Rodríguez was the only individual insider to buy over the year.

The chart below shows insider transactions (by individuals) over the last year. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of growing companies that insiders are buying.

BME:PHM Recent Insider Trading, October 17th 2019

Insider Ownership

Many investors like to check how much of a company is owned by insiders. I reckon it’s a good sign if insiders own a significant number of shares in the company. It appears that Pharma Mar insiders own 12% of the company, worth about €56m. We’ve certainly seen higher levels of insider ownership elsewhere, but these holdings are enough to suggest alignment between insiders and the other shareholders.

So What Does This Data Suggest About Pharma Mar Insiders?

There haven’t been any insider transactions in the last three months — that doesn’t mean much. On a brighter note, the transactions over the last year are encouraging. Insiders own shares in Pharma Mar and we see no evidence to suggest they are worried about the future. If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future.